Aging populations and clearer U.S. drug pricing boost long-term pharma outlook. Leaders like Eli Lilly and Merck lead in ...

Guidance Updates -- Full-year 2025 revenue growth guidance was narrowed to 7.4%-8%, with Adjusted EPS guidance was set at $16 ...

The Japanese yen gained on Tuesday, rebounding from seven consecutive days of losses against the U.S. dollar, after comments ...

Nintendo ( NTDOY +0.00%) and Crocs ( CROX 1.33%) are two stocks I am buying hand over fist before they could soar higher in 2026. Here's why these are great buys for investors as we head to the end of ...

Stablecoin, the purportedly "safer" version of cryptocurrency, is having its moment. On the heels of the GENIUS Act, which Congress passed last July, the value of all stablecoins is now more than $300 ...